One thing the article didn't mention is that Biota is developing a second generation influenza product.
Given the patents expire in 2011 & 2014 in Europe & US, the timing could be just about right.
It appears that none of the potential upside of LANI is reflected in the current share price.
- Forums
- ASX - By Stock
- biota in aft today
One thing the article didn't mention is that Biota is developing...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)